Acuta Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-42,000
| Closed | -$1.91M | – | 62 |
|
|
2016
Q2 | $1.91M | Buy |
+42,000
| New | +$1.91M | 0.92% | 30 |
|
|
2016
Q1 | – | Sell |
-56,000
| Closed | -$3.17M | – | 43 |
|
|
2015
Q4 | $3.17M | Buy |
+56,000
| New | +$3.17M | 1.52% | 18 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 56 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 56 |
|